Journal
HISTOCHEMISTRY AND CELL BIOLOGY
Volume 138, Issue 2, Pages 351-363Publisher
SPRINGER
DOI: 10.1007/s00418-012-0958-8
Keywords
Cystinosis; Cystinosin-LKG
Categories
Funding
- Cystinosis Research Network (Lake Forest, IL, USA)
- Cystinosis Research Foundation (Irvine, CA, USA)
- Fund for Scientific Research, Flanders (Belgium) (F.W.O. Vlaanderen) [1801110N]
Ask authors/readers for more resources
Nephropathic cystinosis is multisystemic progressive disorder caused by mutations of CTNS gene that encodes for the lysosomal cystine co-transporter cystinosin, and for a less abundant isoform termed cystinosin-LKG, which is expressed in not only lysosomes but also other cell compartments. To overcome the absence of high-quality antibodies against cystinosin, we have obtained a rabbit antiserum against cystinosin-LKG and have analyzed in human tissues the expression of the two known cystinosin isoforms by RT-PCR, and the expression of cystinosin-LKG by immunohistochemistry. In most tissues, CTNS-LKG represents 5-20 % of CTNS transcripts, with the exception of the testis that expresses both isoforms in equal proportions. Cystinosin-LKG was found to be highly expressed in renal tubular cells, pancreatic islets of Langerhans, Leydig cells of the testis, mucoserous glands of the bronchial wall, melanocytes and keratinocytes. These results are parallel with many features of cystinosis, such as early onset Fanconi syndrome, male infertility, diabetes mellitus and hypopigmentation. Intermediate expression levels were of the LKG isoform observed in the gastro-intestinal tract and thyroid glands; low levels of expression were observed in the brain, skeletal and cardiac muscles.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available